Involvement of profilin-1 in angiotensin II-induced vascular smooth muscle cell proliferation

Vascular Pharmacology

Volumn 55, Issue 1-3, 2011, Pages 34-41

  Cheng, Jin Fang ^a,c   Ni, Guo Hua ^a,d   Chen, Mei Fang ^a   Li, Yuan Jian ^b   Wang, Yong Jin ^c   Wang, Chang Lu ^a   Yuan, Qiong ^b   Shi, Rui Zheng ^a   Hu, Chang Ping ^b   Yang, Tian Lun ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c CHANGZHI MEDICAL COLLEGE   (China)

^d XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin II; Hypertension; Profilin 1; Proliferation; Vascular smooth muscle cells

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; JANUS KINASE 2; LOSARTAN; PROFILIN; PROFILIN I; SHORT HAIRPIN RNA; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; BLOOD PRESSURE; CELL GROWTH PROCESSES; CELLS, CULTURED; GENE KNOCKDOWN TECHNIQUES; HYPERTENSION; JANUS KINASE 2; LOSARTAN; MALE; MESENTERIC ARTERIES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROFILINS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR, ANGIOTENSIN, TYPE 1; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 80051780569     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2011.04.003     Document Type: Article

References (29)

1. Barry S.P., Davidson S.M., Townsend P.A. Molecular regulation of cardiac hypertrophy. Int. J. Biochem. Cell Biol. 2008, 40:2023-2039.
2. Caglayan E., Romeo G.R., Kappert K., Odenthal M., Südkamp M., Body S.C., Shernan S.K., Hackbusch D., Vantler M., Kazlauskas A., Rosenkranz S. Profilin-1 is expressed in human atherosclerotic plaques and induces atherogenic effects on vascular smooth muscle cells. PLoS One 2010, 5:e13608.
3. Dai Y.P., Bongalon S., Tian H., Parks S.D., Mutafova-Yambolieva V.N., Yamboliev I.A. Upregulation of profilin, cofilin-2 and LIMK2 in cultured pulmonary artery smooth muscle cells and in pulmonary arteries of monocrotaline-treated rats. Vasc. Pharmacol. 2006, 44:275-282.
4. El-Mabrouk M., Touyz R.M., Schiffrin E.L. Differential Ang II-induced growth activation pathways in mesenteric artery smooth muscle cells from SHR. Am. J. Physiol. Heart Circ. Physiol. 2001, 281:H30-H39.
5. Feihl F., Liaudet L., Levy B.I., Waeber B. Hypertension and microvascular remodelling. Cardiovasc. Res. 2008, 78:274-285.
6. Geisterfer A.A., Peach M.J., Owens G.K. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ. Res. 1988, 62:749-756.
7. Grote K., Luchtefeld M., Schieffer B. JANUS under stress-role of JAK/STAT signaling pathway in vascular diseases. Vasc. Pharmacol. 2005, 43:357-363.
8. Hassona M.D.H., Abouelnaga Z.a., Elnakish M.T., Awad M.M., Alhaj M., Goldschmidt-Clermont P.J., Hassanain H. Vascular hypertrophy-associated hypertension of profilin1 transgenic mouse model leads to functional remodeling of peripheral arteries. Am. J. Physiol. Heart Circ. Physiol. 2010, 298:H2112-H2120.
9. Heeneman S., Sluimer J., Daemen M.J.A.P. Angiotensin-converting enzyme and vascular remodeling. Circ. Res. 2007, 101:441-454.
10. Horrevoets A.J.G. Profilin-1: an unexpected molecule linking vascular inflammation to the actin cytoskeleton. Circ. Res. 2007, 101:328-330.
11. Intengan H.D., Schiffrin E.L. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 2001, 38:581-587.
12. Jockusch B.M., Murk K., Rothkegel M. The profile of profilins. Rev. Physiol. Biochem. Pharmacol. 2007, 159:131-149.
13. Kim J.E., Choi H.C. Losartan inhibits vascular smooth muscle cell proliferation through activation of AMP-activated protein kinase. Korean J. Physiol. Pharmacol. 2010, 14:299-304.
14. Korshunov V.A., Berk B.C. Smooth muscle apoptosis and vascular remodeling. Curr. Opin. Hematol. 2008, 15:250-254.
15. Kozaburo H., Takeru N. Adaptation and remodeling of vascular wall; biomechanical response to hypertension. J. Mech. Behav. Biomed. Mater. 2009, 2:3-19.
16. Li J.S., Sharifi A.M., Schiffrin E.L. Effect of AT1 angiotensin-receptor blockade on structure and function of small arteries in SHR. J. Cardiovasc. Pharmacol. 1997, 30:75-83.
17. Marrero M.B., Chieffer B.S., Paxton W.G., Heerdt L., Berk B.C., Delafontaine P., Bernstein K.E. Direct stimulation of JAK/STAT pathway by the angiotensin II AT1 receptor. Nature 1995, 375:P247-P250.
18. Moustafa-Bayoumi M., Alhaj M., El-Sayed O., Wisel S., Chotani M.A., Abouelnaga Z.A., Hassona M.D.H., Rigatto K., Morris M., Nuovo G., Zweier J., Goldschmidt-Clermont P.J., Hassanain H. Vascular hypertrophy and hypertension caused by transgenic overexpression of profilin 1. J. Biol. Chem. 2007, 282:37632-37639.
19. Pierdomenico S., Nicola M.D., Esposito A., Mascio R.D., Ballone E., Lapenna D., Cuccurullo F. Prognostic value of different indices of blood pressure variability in hypertensive patients. Am. J. Hypertens. 2009, 22:842-847.
20. Rawlings J.S., Rosler K.M., Harrison D.A. The JAK/STAT signaling pathway. J. Cell Sci. 2004, 117:1281-1283.
21. Romeo G., Frangioni J.V., Kazlauskas A. Profilin acts downstream of LDL to mediate diabetic endothelial cell dysfunction. FASEB J. 2004, 18:725-727.
22. Romeo G.R., Moulton K.S., Kazlauskas A. Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor null mouse. Circ. Res. 2007, 101:357-367.
23. Shaw S., Wang X.D., Redd H., Alexander G.D., Isales C.M., Marrero M.B. High glucose augments the angiotensin II-induced activation of JAK2 in vascular smooth muscle cells via the polyol pathway. J. Biol. Chem. 2003, 278:30634-30641.
24. Tang D.D., Tan J. Downregulation of profilin with antisense oligodeoxynucleotides inhibits force development during stimulation of smooth muscle. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H1528-H1536.
25. Touyz R.M. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Exp. Physiol. 2005, 90:449-455.
26. Touyz R.M., Schiffrin E.L. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth cells. Pharmacol. Rev. 2000, 52:639-672.
27. Yamazaki T., Komuro I., Yazaki Y. Role of the renin-angiotensin system in cardiac hypertrophy. Am. J. Cardiol. 1999, 83:53H-57H.
28. Zhang Y., Griendling K.K., Dikalova A., Owens G.K., Taylor W.R. Vascular hypertrophy in angiotensin II-induced hypertension is mediated by vascular smooth muscle cell-derived H2O2. Hypertension 2005, 46:732-737.
29. Zhong J.C., Ye J.Y., Jin H.Y., Yu X., Yu H.M., Zhu D.L., Gao P.J., Huang D.Y., Shuster M., Loibner H., Guo J.M., Yu X.Y., Xiao B.X., Gong Z.H., Penninger J.M., Oudit G.Y. Telmisartan attenuates aortic hypertrophy in hypertensive rats by the modulation of ACE2 and profilin-1 expression. Regul. Pept. 2011, 166:90-97.